HemaSphere

Keyphrases

Publications

volume 8, number 7, 2024

Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, Sibylle Cocciardi, Claudia Lengerke, Ulrich Germing, Gerald Wulf, Maisun A Samra, Lino L Teichmann, Michael Lübbert, Michael W M Kühn, Martin Bentz, Jörg Westermann, Lars Bullinger, Verena I Gaidzik, Annika Meid, Sophia Aicher, Frank Stegelmann, Daniela Weber, Anika Schrade, Felicitas Thol, Michael Heuser, Arnold Ganser, Axel Benner, Hartmut Döhner, Konstanze Döhner, null null
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG). HemaSphere 8 (7) (2024)
Christos Varelas, Efthymia Vlachaki, Philippos Klonizakis, Despoina Pantelidou, Fani Minti, Michael Diamantidis, Nikolaos Sabanis, Evdoxia Koravou, Ioanna Christodoulou, Despina Papadopoulou, Stamatia Theodoridou, Tasoula Touloumenidou, Apostolia Papalexandri, Ioanna Sakellari, Sofia Vakalopoulou, Vasilis Perifanis, George Vassilopoulos, Ioannis Mitroulis, Eleni Gavriilaki
Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications. HemaSphere 8 (7) (2024)
Enrico Attardi, Lucia Tiberi, Giorgio Mattiuz, Daniela Formicola, Elia Dirupo, Marco G Raddi, Angela Consagra, Debora Vergani, Rosangela Artuso, Valeria Santini
Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes. HemaSphere 8 (7) (2024)
Enrico Attardi, Lucia Tiberi, Giorgio Mattiuz, Daniela Formicola, Elia Dirupo, Marco G Raddi, Angela Consagra, Debora Vergani, Rosangela Artuso, Valeria Santini
Prospective genetic germline evaluation in a consecutive group of adult patients aged <60 years with myelodysplastic syndromes. HemaSphere 8 (7) (2024)
Michael H Tomasson, Shinsuke Iida, Ruben Niesvizky, Mohamad Mohty, Nizar J Bahlis, Joaquin Martinez-Lopez, Guenther Koehne, Paula Rodriguez Otero, H Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T Sullivan, Alexander M Lesokhin
Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study. HemaSphere 8 (7) (2024)
Audrey Couturier, Martine Escoffre, Frédérique Leh, Anne-Sophie Villoteau, Xavier Palard, Florence Le Jeune, Olivier Decaux, Thierry Lamy, Roch Houot
Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel. HemaSphere 8 (7) (2024)
Emma Kroeze, Michelle M Kleisman, Lennart A Kester, Marijn A Scheijde-Vermeulen, Edwin Sonneveld, Jessica G C Buijs-Gladdines, Melanie M Hagleitner, Friederike A G Meyer-Wentrup, Margreet A Veening, Auke Beishuizen, Jules P P Meijerink, Jan L C Loeffen, Roland P Kuiper
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: A high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker. HemaSphere 8 (7) (2024)
Judith M Boer, Uri Ilan, Aurélie Boeree, Karin P S Langenberg, Jan Koster, Marco J Koudijs, Jayne Y Hehir-Kwa, Stefan Nierkens, Corinne Rossi, Jan J Molenaar, Bianca F Goemans, Monique L den Boer, C Michel Zwaan
Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience. HemaSphere 8 (7) (2024)

volume 8, number 8, 2024

Alexandre V Hirayama, Jocelyn H Wright, Kimberly S Smythe, Salvatore Fiorenza, Akira N Shaw, Jordan Gauthier, David G Maloney, Kikkeri N Naresh, Cecilia C S Yeung, Cameron J Turtle
PD-L1 + macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy. HemaSphere 8 (8) (2024)
Arnon P Kater, Barbara F Eichhorst, Carolyn J Owen, Ulrich Jaeger, Brenda Chyla, Marcus Lefebure, Rosemary Millen, Yanwen Jiang, Maria Thadani-Mulero, Michelle Boyer, John F Seymour
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab. HemaSphere 8 (8) (2024)
Anna M Aalbers, Paul L A van Daele, Virgil A S H Dalm, Peter J M Valk, Marc H G P Raaijmakers
Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome. HemaSphere 8 (8) (2024)
Arnon P Kater, Barbara F Eichhorst, Carolyn J Owen, Ulrich Jaeger, Brenda Chyla, Marcus Lefebure, Rosemary Millen, Yanwen Jiang, Maria Thadani-Mulero, Michelle Boyer, John F Seymour
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab. HemaSphere 8 (8) (2024)
Christian M Vonk, Emma L Boertjes, Francois G Kavelaars, Melissa Rijken, Jolinda M L Konijnenburg, Roxanne E Cromwell, Bob Löwenberg, Tim Grob, Peter J M Valk
Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA . HemaSphere 8 (8) (2024)
Christian M Vonk, Emma L Boertjes, Francois G Kavelaars, Melissa Rijken, Jolinda M L Konijnenburg, Roxanne E Cromwell, Bob Löwenberg, Tim Grob, Peter J M Valk
Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA . HemaSphere 8 (8) (2024)
Panagiotis Baliakas, Bianca Tesi, Jörg Cammenga, Asbjørg Stray-Pedersen, Kirsi Jahnukainen, Mette Klarskov Andersen, Helena Ågerstam, Maria Creignou, Ingunn Dybedal, Klas Raaschou-Jensen, Kirsten Grønbaek, Outi Kilpivaara, Eva Hellström Lindberg, Ulla Waitiovaara-Kautto
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. HemaSphere 8 (8) (2024)
Axel André, Lydia Montes, Damien Roos-Weil, Laurent Frenzel, Marguerite Vignon, Thomas Chalopin, Pierre-Edouard Debureaux, Alexis Talbot, Agathe Farge, Fabrice Jardin, Karim Belhadj, Bruno Royer, Jean-Pierre Marolleau, Bertrand Arnulf, Pierre Morel, Stéphanie Harel
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study. HemaSphere 8 (8) (2024)
Edeghonghon Olayemi
Don't call me "Sickler": Confronting stigma in sickle cell disease. HemaSphere 8 (8) (2024)
Pratik Joshi, Ava Keyvani Chahi, Lina Liu, Steven Moreira, Ana Vujovic, Kristin J Hope
RNA binding protein-directed control of leukemic stem cell evolution and function. HemaSphere 8 (8) (2024)
Rosita Del Prete, Roberta Drago, Federica Nardi, Gaia Bartolini, Erika Bellini, Antonella De Rosa, Silvia Valensin, Anna Kabanova
Robust and cost-effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ-TCL1 model of chronic lymphocytic leukemia. HemaSphere 8 (8) (2024)
Panagiotis Baliakas, Bianca Tesi, Jörg Cammenga, Asbjørg Stray-Pedersen, Kirsi Jahnukainen, Mette Klarskov Andersen, Helena Ågerstam, Maria Creignou, Ingunn Dybedal, Klas Raaschou-Jensen, Kirsten Grønbaek, Outi Kilpivaara, Eva Hellström Lindberg, Ulla Waitiovaara-Kautto
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms. HemaSphere 8 (8) (2024)
Edeghonghon Olayemi
Don't call me "Sickler": Confronting stigma in sickle cell disease. HemaSphere 8 (8) (2024)
Andrew D Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P Collins, Javier L Jiménez, Mark Bishton, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J Phillips, Nagendraprasad Sungala, Gerardo Musuraca, Oonagh Sheehy, Eric Van Den Neste, Mitsuhiko Odera, Lu Miao, Daniel P Gold, Richard G Ghalie, Pier L Zinzani
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study. HemaSphere 8 (8) (2024)
Tanya Freeman, Stephen P Hibbs
What is lost when training goes digital? HemaSphere 8 (8) (2024)
Thijs C J Verheul, Nynke Gillemans, Kerstin Putzker, Rezin Majied, Tingyue Li, Memnia Vasiliou, Bert Eussen, Annelies de Klein, Wilfred F J van IJcken, Emile van den Akker, Marieke von Lindern, Joe Lewis, Ulrike Uhrig, Yukio Nakamura, Thamar van Dijk, Sjaak Philipsen
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds. HemaSphere 8 (8) (2024)
Andrew D Zelenetz, Wojciech Jurczak, Vincent Ribrag, Kim Linton, Graham P Collins, Javier L Jiménez, Mark Bishton, Bhagirathbhai Dholaria, Andrea Mengarelli, Tycel J Phillips, Nagendraprasad Sungala, Gerardo Musuraca, Oonagh Sheehy, Eric Van Den Neste, Mitsuhiko Odera, Lu Miao, Daniel P Gold, Richard G Ghalie, Pier L Zinzani
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study. HemaSphere 8 (8) (2024)
Andrea Duminuco, Joshua Au Yeung, Raj Vaghela, Sukhraj Virdee, Claire Woodley, Susan Asirvatham, Natalia Curto-Garcia, Priya Sriskandarajah, Jennifer O'Sullivan, Hugues de Lavallade, Deepti Radia, Shahram Kordasti, Giuseppe Palumbo, Claire N Harrison, Patrick Harrington
Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms. HemaSphere 8 (8) (2024)
Thijs C J Verheul, Nynke Gillemans, Kerstin Putzker, Rezin Majied, Tingyue Li, Memnia Vasiliou, Bert Eussen, Annelies de Klein, Wilfred F J van IJcken, Emile van den Akker, Marieke von Lindern, Joe Lewis, Ulrike Uhrig, Yukio Nakamura, Thamar van Dijk, Sjaak Philipsen
A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compounds. HemaSphere 8 (8) (2024)
Michela Asperti, Francesca Vinchi
Improving CORM technology for the treatment of delayed hemolytic transfusion reaction. HemaSphere 8 (8) (2024)
Alexandre V Hirayama, Jocelyn H Wright, Kimberly S Smythe, Salvatore Fiorenza, Akira N Shaw, Jordan Gauthier, David G Maloney, Kikkeri N Naresh, Cecilia C S Yeung, Cameron J Turtle
PD-L1 + macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy. HemaSphere 8 (8) (2024)
Tanya Freeman, Stephen P Hibbs
What is lost when training goes digital? HemaSphere 8 (8) (2024)
Ana Luísa Pereira, Serena Galli, Cesar Nombela-Arrieta
Bone marrow niches for hematopoietic stem cells. HemaSphere 8 (8) (2024)
Ana Luísa Pereira, Serena Galli, Cesar Nombela-Arrieta
Bone marrow niches for hematopoietic stem cells. HemaSphere 8 (8) (2024)
Axel André, Lydia Montes, Damien Roos-Weil, Laurent Frenzel, Marguerite Vignon, Thomas Chalopin, Pierre-Edouard Debureaux, Alexis Talbot, Agathe Farge, Fabrice Jardin, Karim Belhadj, Bruno Royer, Jean-Pierre Marolleau, Bertrand Arnulf, Pierre Morel, Stéphanie Harel
Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study. HemaSphere 8 (8) (2024)
Sanaa Khan, Krishnan Vp, Yamini Krishnan, Gazel Sainulabdin, Somdipa Pal, Rincy Mathews, Darshan Kataria, Kunal Sehgal, Purva Kanvinde, Lashkari Harshaprasad, Minnie Bodhanwala, Bharat Agarwal, Ambreen Pandrowala, Prashant Hiwarkar
Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia. HemaSphere 8 (8) (2024)
Inna Y Gong, Daisy Tran, Samuel Saibil, Rob C Laister, John Kuruvilla
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma. HemaSphere 8 (8) (2024)
Inna Y Gong, Daisy Tran, Samuel Saibil, Rob C Laister, John Kuruvilla
Biomarkers of outcome in patients undergoing CD19 CAR-T therapy for large B cell lymphoma. HemaSphere 8 (8) (2024)
Rosita Del Prete, Roberta Drago, Federica Nardi, Gaia Bartolini, Erika Bellini, Antonella De Rosa, Silvia Valensin, Anna Kabanova
Robust and cost-effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ-TCL1 model of chronic lymphocytic leukemia. HemaSphere 8 (8) (2024)
Pratik Joshi, Ava Keyvani Chahi, Lina Liu, Steven Moreira, Ana Vujovic, Kristin J Hope
RNA binding protein-directed control of leukemic stem cell evolution and function. HemaSphere 8 (8) (2024)
Andrea Duminuco, Joshua Au Yeung, Raj Vaghela, Sukhraj Virdee, Claire Woodley, Susan Asirvatham, Natalia Curto-Garcia, Priya Sriskandarajah, Jennifer O'Sullivan, Hugues de Lavallade, Deepti Radia, Shahram Kordasti, Giuseppe Palumbo, Claire N Harrison, Patrick Harrington
Development of a natural language processing pipeline for assessment of cardiovascular risk in myeloproliferative neoplasms. HemaSphere 8 (8) (2024)
Michela Asperti, Francesca Vinchi
Improving CORM technology for the treatment of delayed hemolytic transfusion reaction. HemaSphere 8 (8) (2024)
Anna M Aalbers, Paul L A van Daele, Virgil A S H Dalm, Peter J M Valk, Marc H G P Raaijmakers
Long-term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome. HemaSphere 8 (8) (2024)
Sanaa Khan, Krishnan Vp, Yamini Krishnan, Gazel Sainulabdin, Somdipa Pal, Rincy Mathews, Darshan Kataria, Kunal Sehgal, Purva Kanvinde, Lashkari Harshaprasad, Minnie Bodhanwala, Bharat Agarwal, Ambreen Pandrowala, Prashant Hiwarkar
Disease-burden-adapted immunotherapy protocol for primary refractory or high-risk relapsed pediatric acute lymphoblastic leukemia. HemaSphere 8 (8) (2024)

volume 8, number 9, 2024

Nikoleta Bizymi, Athina Damianaki, Nikoletta Aresti, Anastasios Karasachinidis, Zacharenia Vlata, Matthieu Lavigne, Emmanuel Dialynas, Niki Gounalaki, Irene Stratidaki, Grigorios Tsaknakis, Aristea Batsali, Irene Mavroudi, Maria Velegraki, Ioannis Sperelakis, Charalampos Pontikoglou, Panayotis Verginis, Helen A Papadaki
Characterization of myeloid-derived suppressor cells in the peripheral blood and bone marrow of patients with chronic idiopathic neutropenia. HemaSphere 8 (9) (2024)
Thomas Chatzikonstantinou, Lydia Scarfò, Eva Minga, Georgios Karakatsoulis, Dimitra Chamou, Jana Kotaskova, Gloria Iacoboni, Christos Demosthenous, Elisa Albi, Miguel Alcoceba, Salem Al-Shemari, Thérèse Aurran-Schleinitz, Francesca Bacchiarri, Sofia Chatzileontiadou, Rosa Collado, Zadie Davis, Marcos Daniel de Deus Santos, Maria Dimou, Elena Dmitrieva, David Donaldson, Gimena Dos Santos, Barbara Dreta, Maria Efstathopoulou, Shaimaa El-Ashwah, Alicia Enrico, Andrzej Frygier, Sara Galimberti, Andrea Galitzia, Eva Gimeno, Valerio Guarente, Romain Guieze, Sean Harrop, Eleftheria Hatzimichael, Yair Herishanu, José-Ángel Hernández-Rivas, Ozren Jaksic, Elżbieta Kalicińska, Kamel Laribi, Volkan Karakus, Arnon P Kater, Bonnie Kho, Maria Kislova, Εliana Konstantinou, Maya Koren-Michowitz, Ioannis Kotsianidis, Zuzana Kubova, Jorge Labrador, Deepesh Lad, Luca Laurenti, Thomas Longval, Alberto Lopez-Garcia, Juan Marquet, Stanislava Maslejova, Carlota Mayor-Bastida, Biljana Mihaljevic, Ivana Milosevic, Fatima Miras, Riccardo Moia, Marta Morawska, Uttam K Nath, Almudena Navarro-Bailón, Jacopo Olivieri, Irina Panovska-Stavridis, Maria Papaioannou, Cheyenne Pierie, Anna Puiggros, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Mattia Schipani, Annett Schiwitza, Yandong Shen, Tereza Shokralla, Martin Simkovic, Svetlana Smirnova, Dina S A Soliman, Stephan Stilgenbauer, Tamar Tadmor, Kristina Tomic, Eric Tse, Theodoros Vassilakopoulos, Andrea Visentin, Candida Vitale, George Vrachiolias, Vojin Vukovic, Renata Walewska, Zhenshu Xu, Munci Yagci, Lucrecia Yañez, Mohamed Yassin, Jana Zuchnicka, David Oscier, Alessandro Gozzetti, Panagiotis Panagiotidis, Francesc Bosch, Paolo Sportoletti, Blanca Espinet, Gerassimos A Pangalis, Viola M Popov, Stephen Mulligan, Maria Angelopoulou, Fatih Demirkan, Tomas Papajík, Bella Biderman, Roberta Murru, Marta Coscia, Constantine Tam, Antonio Cuneo, Gianluca Gaidano, Rainer Claus, Niki Stavroyianni, Livio Trentin, Darko Antic, Lukas Smolej, Olga B Kalashnikova, Mark Catherwood, Martin Spacek, Sarka Pospisilova, Michael Doubek, Eugene Nikitin, Anastasia Chatzidimitriou, Paolo Ghia, Kostas Stamatopoulos
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL. HemaSphere 8 (9) (2024)
Jurrian K de Kanter, Alexander S Steemers, Daniel Montiel Gonzalez, Ravian L van Ineveld, Catharina Blijleven, Niels Groenen, Laurianne Trabut, Marijn A Scheijde-Vermeulen, Liset Westera, Auke Beishuizen, Anne C Rios, Frank C P Holstege, Arianne M Brandsma, Thanasis Margaritis, Ruben van Boxtel, Friederike A G Meyer-Wentrup
Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes. HemaSphere 8 (9) (2024)
Paolo Mazzeo, Christina Ganster, John Wiedenhöft, Katayoon Shirneshan, Katharina Rittscher, Elzbieta B Brzuszkiewicz, Doris Steinemann, Maximilian Schieck, Catharina Müller-Thomas, Hannes Treiber, Friederike Braulke, Ulrich Germing, Katja Sockel, Ekaterina Balaian, Julie Schanz, Uwe Platzbecker, Katharina S Götze, Detlef Haase
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS. HemaSphere 8 (9) (2024)
Naja Nyffenegger, Anna Flace, Ahmet Varol, Patrick Altermatt, Cédric Doucerain, Hanna Sundstrom, Franz Dürrenberger, Vania Manolova
The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis. HemaSphere 8 (9) (2024)
David G Kent
Battle of the sexes: Understanding donor:recipient sex differences in transplantation biology. HemaSphere 8 (9) (2024)
Louise Caldwell, Stephen P Hibbs
Informed consent is almost impossible. HemaSphere 8 (9) (2024)
Kai Hübel, Mark Bower, Igor Aurer, Mariana Bastos-Oreiro, Caroline Besson, Uta Brunnberg, Chiara Cattaneo, Simon Collins, Kate Cwynarski, Alessia D Pria, Marcus Hentrich, Christian Hoffmann, Marie J Kersten, Silvia Montoto, Jose-Tomas Navarro, Eric Oksenhendler, Alessandro Re, Josep-Maria Ribera, Philipp Schommers, Bastian von Tresckow, Christian Buske, Martin Dreyling, Andy Davies, null null
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. HemaSphere 8 (9) (2024)